Raymond James Financial Services Advisors Inc. Buys 3,907 Shares of National Health Investors, Inc. (NYSE:NHI)

Raymond James Financial Services Advisors Inc. increased its stake in shares of National Health Investors, Inc. (NYSE:NHI) by 14.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 30,971 shares of the real estate investment trust’s stock after acquiring an additional 3,907 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in National Health Investors were worth $1,730,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of NHI. Norges Bank bought a new position in shares of National Health Investors during the 4th quarter worth approximately $21,037,000. State Street Corp lifted its position in shares of National Health Investors by 15.9% during the 1st quarter. State Street Corp now owns 2,186,194 shares of the real estate investment trust’s stock worth $130,904,000 after buying an additional 299,737 shares during the period. Millennium Management LLC lifted its position in shares of National Health Investors by 7,218.8% during the 2nd quarter. Millennium Management LLC now owns 258,574 shares of the real estate investment trust’s stock worth $15,672,000 after buying an additional 255,041 shares during the period. Land & Buildings Investment Management LLC bought a new position in shares of National Health Investors during the 3rd quarter worth approximately $11,642,000. Finally, Marshall Wace LLP bought a new position in shares of National Health Investors during the 4th quarter worth approximately $7,899,000. Institutional investors own 62.51% of the company’s stock.

National Health Investors Trading Up 0.9 %

NHI stock opened at $58.88 on Friday. The company has a market cap of $2.56 billion, a P/E ratio of 18.81 and a beta of 0.95. National Health Investors, Inc. has a twelve month low of $47.54 and a twelve month high of $62.93. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.90. The business has a fifty day moving average of $57.94 and a 200-day moving average of $54.96.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 3rd. Stockholders of record on Thursday, March 28th will be given a dividend of $0.90 per share. The ex-dividend date is Wednesday, March 27th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 6.11%. National Health Investors’s payout ratio is currently 115.02%.

Insider Buying and Selling

In related news, Director Charlotte A. Swafford acquired 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The stock was acquired at an average cost of $58.69 per share, with a total value of $586,900.00. Following the completion of the purchase, the director now directly owns 110,185 shares in the company, valued at $6,466,757.65. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 8.21% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on NHI. BMO Capital Markets upgraded National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price objective for the company in a research report on Tuesday, March 12th. Wedbush lifted their price objective on National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a research report on Monday, March 18th. Truist Financial lifted their price objective on National Health Investors from $55.00 to $58.00 and gave the company a “hold” rating in a research report on Thursday, April 4th. Wells Fargo & Company upgraded National Health Investors from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $55.00 to $63.00 in a research report on Monday, February 26th. Finally, Deutsche Bank Aktiengesellschaft began coverage on National Health Investors in a research report on Tuesday, January 30th. They issued a “buy” rating and a $69.00 price objective for the company. Four research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $60.50.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.